ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 268 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q1 2018. The put-call ratio across all filers is 1.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,552,780 | -7.9% | 727,000 | -11.7% | 0.02% | -7.7% |
Q2 2023 | $10,368,540 | +20.6% | 822,900 | +24.9% | 0.03% | +18.2% |
Q1 2023 | $8,596,035 | -39.3% | 658,700 | -18.0% | 0.02% | -45.0% |
Q4 2022 | $14,171,976 | +40.6% | 803,400 | +21.4% | 0.04% | +37.9% |
Q3 2022 | $10,082,000 | +247.9% | 662,000 | +238.8% | 0.03% | +262.5% |
Q2 2022 | $2,898,000 | +41.4% | 195,400 | +114.7% | 0.01% | +60.0% |
Q1 2022 | $2,049,000 | -69.3% | 91,000 | -74.8% | 0.01% | -72.2% |
Q2 2021 | $6,680,000 | +968.8% | 360,903 | +733.4% | 0.02% | +800.0% |
Q4 2020 | $625,000 | +144.1% | 43,303 | +37.5% | 0.00% | +100.0% |
Q3 2020 | $256,000 | -67.8% | 31,503 | -73.2% | 0.00% | -50.0% |
Q2 2020 | $795,000 | +1.8% | 117,503 | +6.0% | 0.00% | -33.3% |
Q1 2020 | $781,000 | +147.9% | 110,903 | +309.2% | 0.00% | +200.0% |
Q2 2019 | $315,000 | +77.0% | 27,103 | +46.5% | 0.00% | – |
Q4 2018 | $178,000 | +6.6% | 18,503 | +33.0% | 0.00% | – |
Q2 2018 | $167,000 | +13.6% | 13,913 | +16.8% | 0.00% | – |
Q1 2018 | $147,000 | -83.6% | 11,913 | -80.6% | 0.00% | -100.0% |
Q4 2017 | $894,000 | -86.6% | 61,413 | -86.9% | 0.00% | -89.5% |
Q3 2017 | $6,651,000 | -44.8% | 467,416 | -50.5% | 0.02% | -52.5% |
Q2 2017 | $12,047,000 | -21.2% | 944,116 | -21.7% | 0.04% | -20.0% |
Q1 2017 | $15,293,000 | +45.6% | 1,206,079 | +17.2% | 0.05% | +25.0% |
Q4 2016 | $10,503,000 | +67.9% | 1,028,698 | +116.5% | 0.04% | +48.1% |
Q3 2016 | $6,257,000 | +27.8% | 475,090 | +23.2% | 0.03% | +8.0% |
Q2 2016 | $4,897,000 | +2491.0% | 385,590 | +2598.3% | 0.02% | +2400.0% |
Q1 2016 | $189,000 | -84.4% | 14,290 | -85.4% | 0.00% | -87.5% |
Q3 2015 | $1,210,000 | -83.9% | 97,590 | -82.3% | 0.01% | -86.2% |
Q2 2015 | $7,533,000 | -9.7% | 550,690 | -21.1% | 0.06% | -9.4% |
Q1 2015 | $8,344,000 | +382.9% | 697,690 | +415.7% | 0.06% | +357.1% |
Q4 2014 | $1,728,000 | +354.7% | 135,290 | +471.1% | 0.01% | +366.7% |
Q2 2014 | $380,000 | – | 23,690 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kent Lake Capital LLC | 925,000 | $12,154,500 | 4.67% |
EVR Research LP | 1,289,037 | $16,937,946 | 4.48% |
Tamarack Advisers, LP | 435,000 | $5,715,900 | 3.70% |
KESTREL INVESTMENT MANAGEMENT CORP | 263,900 | $3,468 | 2.19% |
Tamarack Advisers, LP | 200,000 | $2,628,000 | 1.70% |
Numerai GP LLC | 274,319 | $3,604,552 | 1.20% |
Smith, Graham & Co., Investment Advisors, LP | 525,915 | $6,910,523 | 0.86% |
PEREGRINE CAPITAL MANAGEMENT LLC | 585,254 | $7,690,238 | 0.23% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 2,401,754 | $31,559,048 | 0.22% |
FULLER & THALER ASSET MANAGEMENT, INC. | 2,543,242 | $33,418,194 | 0.19% |